About this trial
Neuroscent aims to analyze EEG signals induced by olfactory stimuli in individuals with normal and impaired olfactory functions, with a focus on patients with tinnitus. The study seeks to develop reliable diagnostic methods using EEG to differentiate between normosmic and hyposmic subjects during olfactory tests, potentially enhancing our understanding of the brain's response to olfactory stimuli. This 24-month interventional study with a device to be patented will involve 1000 participants and aims to establish more effective diagnostic and therapeutic tools for olfactory disorders
Eligibility criteria
Qualifiers
Subjects over 18 years of age who have given consent for the collection of specified data, including medical history and personal information, for the purposes of project implementation and in accordance with the ethical standards of the institutions where the project will be conducted.
Disqualifiers
Previous fractures of the facial bones, particularly the ethmoid bone.
Active tumors of the brain or face, including tumors of the nose, paranasal sinuses, oral cavity, or nasopharynx.
Active nasal-sinus conditions, particularly radiologically proven sinusitis.
Mass in the pontocerebellar angle, especially schwannoma of the VIII nerve.
Trial design
Treatments tested in this trial
- Sniffin'Sticks